2-71569911-A-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001130987.2(DYSF):​c.2956A>T​(p.Met986Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00184 in 1,614,090 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M986I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0011 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0019 ( 8 hom. )

Consequence

DYSF
NM_001130987.2 missense

Scores

7
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:9B:4O:2

Conservation

PhyloP100: 4.96

Publications

6 publications found
Variant links:
Genes affected
DYSF (HGNC:3097): (dysferlin) The protein encoded by this gene belongs to the ferlin family and is a skeletal muscle protein found associated with the sarcolemma. It is involved in muscle contraction and contains C2 domains that play a role in calcium-mediated membrane fusion events, suggesting that it may be involved in membrane regeneration and repair. In addition, the protein encoded by this gene binds caveolin-3, a skeletal muscle membrane protein which is important in the formation of caveolae. Specific mutations in this gene have been shown to cause autosomal recessive limb girdle muscular dystrophy type 2B (LGMD2B) as well as Miyoshi myopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2008]
DYSF Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • neuromuscular disease caused by qualitative or quantitative defects of dysferlin
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • autosomal recessive limb-girdle muscular dystrophy type 2B
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • distal myopathy with anterior tibial onset
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • congenital myopathy, Paradas type
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Miyoshi myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.016784072).
BP6
Variant 2-71569911-A-T is Benign according to our data. Variant chr2-71569911-A-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 196022.
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.00191 (2792/1461756) while in subpopulation NFE AF = 0.00227 (2528/1111960). AF 95% confidence interval is 0.0022. There are 8 homozygotes in GnomAdExome4. There are 1394 alleles in the male GnomAdExome4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 8 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DYSFNM_001130987.2 linkc.2956A>T p.Met986Leu missense_variant Exon 27 of 56 ENST00000410020.8 NP_001124459.1 O75923-13
DYSFNM_003494.4 linkc.2902A>T p.Met968Leu missense_variant Exon 27 of 55 ENST00000258104.8 NP_003485.1 O75923-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DYSFENST00000410020.8 linkc.2956A>T p.Met986Leu missense_variant Exon 27 of 56 1 NM_001130987.2 ENSP00000386881.3 O75923-13
DYSFENST00000258104.8 linkc.2902A>T p.Met968Leu missense_variant Exon 27 of 55 1 NM_003494.4 ENSP00000258104.3 O75923-1

Frequencies

GnomAD3 genomes
AF:
0.00114
AC:
174
AN:
152216
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.0110
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.00113
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00182
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00140
AC:
352
AN:
251262
AF XY:
0.00147
show subpopulations
Gnomad AFR exome
AF:
0.000493
Gnomad AMR exome
AF:
0.000492
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00153
Gnomad NFE exome
AF:
0.00227
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.00191
AC:
2792
AN:
1461756
Hom.:
8
Cov.:
32
AF XY:
0.00192
AC XY:
1394
AN XY:
727168
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33478
American (AMR)
AF:
0.000380
AC:
17
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00110
AC:
95
AN:
86218
European-Finnish (FIN)
AF:
0.00137
AC:
73
AN:
53394
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00227
AC:
2528
AN:
1111960
Other (OTH)
AF:
0.00114
AC:
69
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
161
322
483
644
805
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00114
AC:
174
AN:
152334
Hom.:
1
Cov.:
33
AF XY:
0.00107
AC XY:
80
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41580
American (AMR)
AF:
0.000457
AC:
7
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00207
AC:
10
AN:
4828
European-Finnish (FIN)
AF:
0.00113
AC:
12
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00182
AC:
124
AN:
68034
Other (OTH)
AF:
0.00237
AC:
5
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
11
22
34
45
56
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00164
Hom.:
0
Bravo
AF:
0.00122
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.00208
AC:
8
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00244
AC:
21
ExAC
AF:
0.00151
AC:
183

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:9Benign:4Other:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:4Benign:2Other:1
May 20, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 24239059, 30564623, 18832576, 24438169) -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 17, 2021
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

DYSF: BS2 -

Nov 19, 2015
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Likely benign and reported on 05-29-2019 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -

Mar 08, 2023
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Neuromuscular disease caused by qualitative or quantitative defects of dysferlin Uncertain:1Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Jan 14, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Limb-girdle muscular dystrophy, recessive Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Distal myopathy with anterior tibial onset;C1850889:Autosomal recessive limb-girdle muscular dystrophy type 2B;C4551973:Miyoshi muscular dystrophy 1 Uncertain:1
Oct 20, 2021
Myriad Genetics, Inc.
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NM_003494.3(DYSF):c.2902A>T(M968L) is a missense variant classified as a variant of uncertain significance in the context of dysferlinopathy. M968L has been observed in cases with relevant disease (PMID: 18832576, 30564623, 24239059). Functional assessments of this variant are not available in the literature. M968L has been observed in population frequency databases (gnomAD: NFE 0.22%). In summary, there is insufficient evidence to classify NM_003494.3(DYSF):c.2902A>T(M968L) as pathogenic or benign. Please note: this variant was assessed in the context of healthy population screening. -

Miyoshi muscular dystrophy 1 Uncertain:1
May 18, 2021
Pars Genome Lab
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Miyoshi myopathy Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive limb-girdle muscular dystrophy type 2B Benign:1
Jan 12, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

DYSF-related disorder Other:1
-
GenomeConnect - Invitae Patient Insights Network
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Uncertain
-0.070
CADD
Uncertain
24
DANN
Benign
0.97
DEOGEN2
Benign
0.22
.;.;.;.;T;.;.;.;.;.;.
Eigen
Benign
0.089
Eigen_PC
Uncertain
0.23
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.79
T;T;T;T;T;T;T;T;T;T;T
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.017
T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.60
D
MutationAssessor
Benign
1.2
.;.;L;.;L;.;.;.;.;.;.
PhyloP100
5.0
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-1.2
N;N;N;N;N;N;N;N;N;N;N
REVEL
Uncertain
0.43
Sift
Benign
0.075
T;T;T;T;T;T;T;T;T;T;T
Sift4G
Benign
0.072
T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.22
B;B;B;B;B;B;B;B;B;B;B
Vest4
0.55
MutPred
0.48
.;.;Gain of relative solvent accessibility (P = 0.0166);.;Gain of relative solvent accessibility (P = 0.0166);.;.;.;.;.;.;
MVP
0.73
MPC
0.18
ClinPred
0.010
T
GERP RS
5.2
Varity_R
0.43
gMVP
0.39
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144636654; hg19: chr2-71797041; API